Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2005;331:695 (24 September), doi:10.1136/bmj.331.7518.695-a
| The first 150 words of the full text of this article appear below. |
EDITORClark's discussion of the future of academic medicine is stimulating but misdirected.1 Medical science policy should aim primarily to enhance therapeutic progress and reverse the decline in major, clinically relevant "breakthroughs'" over recent decades.2 3
|
Current medical research mostly constitutes an "applied" science aiming at steady, predictable advance by an accumulation of small improvements.4 But more radical and risky strategies are required to solve problems which are not yielding to established methods.2 3
We need a specialised research system of '"pure" medical science, whose role would be to generate and critically evaluate ambitious and potentially important theories, techniques, treatments, and technologies.4 Pure science units might evolve from existing world class applied medical research institutions, but such units must have distinctive objectives, evaluation procedures, organisation, career paths, and funding arrangements.
Will it happen? Perhaps: imaginative patrons in the funding foundations might be attracted by the prestige of helping to establish an
Bruce Charlton, editor in chief, Medical Hypotheses
University of Newcastle upon Tyne, Newcastle upon Tyne NE1 7RU Bruce.Charlton@newcastle.ac.uk